Nina Mehta, Andy Goren; J Cosmet Dermatol. 4 April 2024. Online ahead of print. ISSN: 1473-2130 eISSN: 1473-2165; https://doi.org/10.1111/jocd.16322
Nina Mehta, Sam Huang, Rachita Dhura, Carlos Wambier, Daniel do Nascimento Fonesca, Sabrina Little, Andy Goren; J Cosmet Dermatol. 2023 Aug 28. Online ahead of print. PMID: 37638619 DOI: 10.1111/jocd.15980.
1: Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, Goldust M.
Rosacea Management: A Comprehensive Review. J Cosmet Dermatol. 2022 Feb 1. doi:
10.1111/jocd.14816. Epub ahead of print. PMID: 35104917.
Khazdair MR, Goren A. Can sunlight affect COVID-19 outcomes? What is the
available evidence? Clin Exp Emerg Med. 2021 Sep;8(3):249-250. doi:
10.15441/ceem.21.045. Epub 2021 Sep 30. PMID: 34649415; PMCID: PMC8517466.
Abrantes TF, Artounian KA, Falsey R, Simão JCL, Vañó-Galván S, Ferreira SB, Davis TL, Ridenour W, Goren A, Tosti A, Wambier CG. Time of onset and duration of post-COVID-19 acute telogen effluvium. J Am Acad Dermatol. 2021 Oct;85(4):975-976. doi: 10.1016/j.jaad.2021.07.021. Epub 2021 Jul 21. PMID: 34302903; PMCID: PMC8294706.
Cadegiani FA, Goren A, Wambier CG, McCoy J. Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients. New Microbes New Infect. 2021 Sep;43:100915. doi: 10.1016/j.nmni.2021.100915. Epub 2021 Jul 7. PMID: 34249367; PMCID: PMC8262389.